NIGHTINGALE HEALTH OYJ |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.975 EUR | -2.71% |
|
+17.56% | +76.97% |
| Jun. 28 | Eurofins Scientific Unit to Sell Nightingale's Blood Analysis test in the US | MT |
| Jun. 28 | 23andMe to Offer Free Blood Testing for Members in Pilot Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Nightingale Health Oyj is a Finland-based health technology company that aims to promote preventative health and help people stay healthy. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The Company provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Companyâs subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The Company owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
2.03
EUR
Average target price
1.6
EUR
Spread / Average Target
-21.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +76.97% | 132M | |
| +42.32% | 9.46B | |
| +33.47% | 4.36B | |
| -41.72% | 2.21B | |
| -7.91% | 1.63B | |
| -30.48% | 1.2B | |
| -42.86% | 974M | |
| +4.72% | 936M | |
| -46.87% | 739M | |
| -32.44% | 581M |
- Stock Market
- Equities
- HEALTH Stock
- News Nightingale Health Oyj
- Nightingale Health Lands Five New Health Risk Detection Patents in Finland
